title: C-reactive protein as a marker for tissue damage in patients undergoing ESWL with or without retrograde stone manipulation.
abstract: In this study we attempt to evaluate the advantages and disadvantages of extracorporeal shock wave lithotripsy (ESWL) in situ versus retrograde stone manipulation before ESWL (ESWL+push back) in patients with proximal ureteral stones with regard to tissue damage and inflammatory processes. Several studies have revealed that C-reactive protein (CRP) is a useful marker for tissue damage and inflammation. Thirty patients following primary ESWL in situ, with residual calculi, were randomized to retreatment with ESWL in situ or ESWL+push back. Four of 15 patients in the ESWL+push back group demonstrated an increase in CRP levels after treatment compared with no significant increase in 15 patients in the ESWL in situ group. We conclude that ESWL+push back did not cause significantly higher CRP values than ESWL in situ. ESWL+push back may cause irritation, inflammation, and slight tissue damage in some cases; however, these effects are probably minor and would not contraindicate its use. The implications of this study are that serum CRP levels may be utilized to monitor tissue injury in patients undergoing auxiliary procedures.
authors.affiliation: Department of Urology, Technical University of Aachen, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Planz
authors.forename: J M
authors.initials: JM
authors.lastname: Wolff
authors.forename: A
authors.initials: A
authors.lastname: Gutersohn
authors.forename: D S
authors.initials: DS
authors.lastname: Stampfer
authors.forename: G
authors.initials: G
authors.lastname: Jakse
mesh_terms: D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000209:etiology; D008096:Lithotripsy / Q000009:adverse effects; D009391:Nephelometry and Turbidimetry; D011183:Postoperative Complications / Q000097:blood; D016896:Treatment Outcome; D014513:Ureter / Q000293:injuries; D014514:Ureteral Calculi / Q000097:blood / Q000628:therapy*; D018666:Ureteroscopy
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein